These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Interaction with ERp57 is required for progranulin protection against Type 2 Gaucher disease. Liu Y; Zhao X; Jian J; Hasan S; Liu C Biosci Trends; 2023 May; 17(2):126-135. PubMed ID: 36889696 [TBL] [Abstract][Full Text] [Related]
27. Molecular regulations and therapeutic targets of Gaucher disease. Chen Y; Sud N; Hettinghouse A; Liu CJ Cytokine Growth Factor Rev; 2018 Jun; 41():65-74. PubMed ID: 29699937 [TBL] [Abstract][Full Text] [Related]
28. Optimization and biological evaluation of celastrol derivatives as Hsp90-Cdc37 interaction disruptors with improved druglike properties. Jiang F; Wang HJ; Bao QC; Wang L; Jin YH; Zhang Q; Jiang D; You QD; Xu XL Bioorg Med Chem; 2016 Nov; 24(21):5431-5439. PubMed ID: 27647369 [TBL] [Abstract][Full Text] [Related]
29. Identification of miRNAs that modulate glucocerebrosidase activity in Gaucher disease cells. Siebert M; Westbroek W; Chen YC; Moaven N; Li Y; Velayati A; Saraiva-Pereira ML; Martin SE; Sidransky E RNA Biol; 2014; 11(10):1291-300. PubMed ID: 25584808 [TBL] [Abstract][Full Text] [Related]
30. Specific association of a set of molecular chaperones including HSP90 and Cdc37 with MOK, a member of the mitogen-activated protein kinase superfamily. Miyata Y; Ikawa Y; Shibuya M; Nishida E J Biol Chem; 2001 Jun; 276(24):21841-8. PubMed ID: 11278794 [TBL] [Abstract][Full Text] [Related]
31. The Hsp70-Hsp90 Chaperone Cascade in Protein Folding. Morán Luengo T; Mayer MP; Rüdiger SGD Trends Cell Biol; 2019 Feb; 29(2):164-177. PubMed ID: 30502916 [TBL] [Abstract][Full Text] [Related]
32. Ex vivo and in vivo effects of isofagomine on acid β-glucosidase variants and substrate levels in Gaucher disease. Sun Y; Liou B; Xu YH; Quinn B; Zhang W; Hamler R; Setchell KD; Grabowski GA J Biol Chem; 2012 Feb; 287(6):4275-87. PubMed ID: 22167193 [TBL] [Abstract][Full Text] [Related]
33. Glucosylceramide mimics: highly potent GCase inhibitors and selective pharmacological chaperones for mutations associated with types 1 and 2 Gaucher disease. Schönemann W; Gallienne E; Ikeda-Obatake K; Asano N; Nakagawa S; Kato A; Adachi I; Górecki M; Frelek J; Martin OR ChemMedChem; 2013 Nov; 8(11):1805-17. PubMed ID: 24115322 [TBL] [Abstract][Full Text] [Related]
34. Binding of 3,4,5,6-tetrahydroxyazepanes to the acid-β-glucosidase active site: implications for pharmacological chaperone design for Gaucher disease. Orwig SD; Tan YL; Grimster NP; Yu Z; Powers ET; Kelly JW; Lieberman RL Biochemistry; 2011 Dec; 50(49):10647-57. PubMed ID: 22047104 [TBL] [Abstract][Full Text] [Related]
35. The effect of celastrol, a triterpene with antitumorigenic activity, on conformational and functional aspects of the human 90kDa heat shock protein Hsp90α, a chaperone implicated in the stabilization of the tumor phenotype. Zanphorlin LM; Alves FR; Ramos CH Biochim Biophys Acta; 2014 Oct; 1840(10):3145-52. PubMed ID: 24954307 [TBL] [Abstract][Full Text] [Related]
36. Cholesterol glucosylation is catalyzed by transglucosylation reaction of β-glucosidase 1. Akiyama H; Kobayashi S; Hirabayashi Y; Murakami-Murofushi K Biochem Biophys Res Commun; 2013 Nov; 441(4):838-43. PubMed ID: 24211208 [TBL] [Abstract][Full Text] [Related]
37. Gaucher disease-associated glucocerebrosidases show mutation-dependent chemical chaperoning profiles. Sawkar AR; Adamski-Werner SL; Cheng WC; Wong CH; Beutler E; Zimmer KP; Kelly JW Chem Biol; 2005 Nov; 12(11):1235-44. PubMed ID: 16298303 [TBL] [Abstract][Full Text] [Related]
38. Molecular chaperone complexes with antagonizing activities regulate stability and activity of the tumor suppressor LKB1. Gaude H; Aznar N; Delay A; Bres A; Buchet-Poyau K; Caillat C; Vigouroux A; Rogon C; Woods A; Vanacker JM; Höhfeld J; Perret C; Meyer P; Billaud M; Forcet C Oncogene; 2012 Mar; 31(12):1582-91. PubMed ID: 21860411 [TBL] [Abstract][Full Text] [Related]
39. Silencing of the Hsp70-specific nucleotide-exchange factor BAG3 corrects the F508del-CFTR variant by restoring autophagy. Hutt DM; Mishra SK; Roth DM; Larsen MB; Angles F; Frizzell RA; Balch WE J Biol Chem; 2018 Aug; 293(35):13682-13695. PubMed ID: 29986884 [TBL] [Abstract][Full Text] [Related]
40. Synergistic anticancer effects of triptolide and celastrol, two main compounds from thunder god vine. Jiang QW; Cheng KJ; Mei XL; Qiu JG; Zhang WJ; Xue YQ; Qin WM; Yang Y; Zheng DW; Chen Y; Wei MN; Zhang X; Lv M; Chen MW; Wei X; Shi Z Oncotarget; 2015 Oct; 6(32):32790-804. PubMed ID: 26447544 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]